News
New Immunotherapy Combo Shows Promise for Triple-Negative Breast Cancer
An ongoing trial is evaluating multiple treatment combinations in patients with locally advanced or metastatic TNBC.
News
ART Safe for Breast Cancer Survivors with BRCA1/2 Mutations
Researchers compare maternal and fetal outcomes between those who conceived spontaneously versus those using ART in this high-risk population
News
Blood Test Shows Promise for Improving CRC Screening
Researchers evaluate new cfDNA blood-based test’s ability to detect CRC.
News
Circulating Tumor DNA Predicts Early Treatment Response in Patients With HER2-Positive Cancers
New study results suggest ctDNA dynamics provide an early window into predicting response to targeted therapies in patients with HER2-altered...
News
Repeat MCED Testing May ID Early-Stage and Unscreened Cancers
Eight of 26 patients with cancer signals detected through MCED had cancer.
News
Combo Therapy Prolongs Survival in Gastric Cancer Patients, Regardless of PD-L1 Expression
Researchers evaluate the efficacy and safety of first-line cadonilimab plus standard chemotherapy in patients with advanced or metastatic gastric...
News
Care for patients with gout needs improvement, says doctor
Failure to understand the gout disease process and goals of urate-lowering therapy (ULT) is a key barrier to achieving optimal gout therapy.
News
Expert discusses which diets are best, based on the evidence
The Mediterranean diet is not only helpful for losing weight but also can reduce the risk of various chronic diseases.
News
New drugs in primary care: Lessons learned from COVID-19
Nirmatrelvir-ritonavir has helped keep many patients out of the hospital, says internist.
News
Medications provide best risk-to-benefit ratio for weight loss, says expert
Surgery provides the most weight loss, but has the greatest risk, according to an endocrinology, diabetes, and metabolism professor.
News
Cautious optimism for new Alzheimer’s disease biomarkers and treatments, expert says
“The greatest challenge is cost, as blood-based biomarkers are not currently covered by insurance and still rather costly.”
News
New blood pressure thresholds: How do they affect the evaluation and treatment of hypertension?
In a major shift in the definition of hypertension, new guidelines reclassified 130/80 mm Hg as high blood pressure.